Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10 | $10 | $10 | $11 |
| % Growth | -1.6% | -3.3% | -7.4% | – |
| Cost of Goods Sold | $2 | $3 | $2 | $2 |
| Gross Profit | $7 | $7 | $8 | $9 |
| % Margin | 76.1% | 74.2% | 77.6% | 80.8% |
| R&D Expenses | $2 | $3 | $3 | $3 |
| G&A Expenses | $2 | $2 | $2 | $3 |
| SG&A Expenses | $2 | $3 | $2 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $6 |
| Operating Income | $2 | $2 | $3 | $3 |
| % Margin | 25.7% | 21.3% | 28.4% | 25.4% |
| Other Income/Exp. Net | -$1 | -$1 | $1 | -$1 |
| Pre-Tax Income | $2 | $1 | $4 | $2 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | $2 | $1 | $3 | $2 |
| % Margin | 16.9% | 11.8% | 29.9% | 14.2% |
| EPS | 11.2 | 8.02 | 20.97 | 10.44 |
| % Growth | 39.7% | -61.8% | 100.9% | – |
| EPS Diluted | 11.19 | 7.97 | 20.87 | 10.4 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $1 | $0 |
| EBITDA | $3 | $2 | $4 | $4 |
| % Margin | 31% | 24.2% | 34.8% | 35.7% |